International Journal of Breast Cancer

Wiley

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

International Journal of Breast Cancer is an open-access journal published by Wiley in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,100 USD. Declared review time at DOAJ: 19 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Wiley
ISSN
2090-3170 · 2090-3189
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
1,100 USD
Articles in DOAJ
377
Declared review time
19 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2011-04-07
Indexing
DOAJ
APC
1,100 USD
Declared review time (DOAJ)
19 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

377

Most recent article

last month

Average review time (journal-declared via DOAJ)

19weeks

Works in OpenAlex

377

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

47

i10-index

208

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2026-03-12
Added to DOAJ
2011-04-07
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPMCPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
97%
ORCID iDs in current deposits
97%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101568103
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • Breast Cancer Treatment Studies
  • Breast Cancer Treatment Studies
  • Breast Lesions and Carcinomas
  • Breast Lesions and Carcinomas
  • Global Cancer Incidence and Screening
  • Global Cancer Incidence and Screening
  • HER2/EGFR in Cancer Research
  • HER2/EGFR in Cancer Research
Show all subjects (50)
  • Breast Implant and Reconstruction
  • Breast Implant and Reconstruction
  • BRCA gene mutations in cancer
  • BRCA gene mutations in cancer
  • Cancer Risks and Factors
  • Cancer Risks and Factors
  • Cancer Cells and Metastasis
  • Cancer Cells and Metastasis
  • AI in cancer detection
  • AI in cancer detection
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Cancer survivorship and care
  • Cancer survivorship and care
  • Advanced Breast Cancer Therapies
  • Advanced Breast Cancer Therapies
  • Colorectal Cancer Screening and Detection
  • Colorectal Cancer Screening and Detection
  • Estrogen and related hormone effects
  • Estrogen and related hormone effects
  • Cervical Cancer and HPV Research
  • Cervical Cancer and HPV Research
  • Cancer Treatment and Pharmacology
  • Cancer Treatment and Pharmacology
  • Advanced Radiotherapy Techniques
  • Digital Radiography and Breast Imaging
  • Advanced Radiotherapy Techniques
  • Digital Radiography and Breast Imaging
  • Economic and Financial Impacts of Cancer
  • Cancer and Skin Lesions
  • Cancer and Skin Lesions
  • Economic and Financial Impacts of Cancer
  • MRI in cancer diagnosis
  • MRI in cancer diagnosis
  • Cancer Immunotherapy and Biomarkers
  • Male Breast Health Studies
  • Male Breast Health Studies
  • Immunotherapy and Immune Responses
  • Reconstructive Surgery and Microvascular Techniques
  • Immunotherapy and Immune Responses
  • Reconstructive Surgery and Microvascular Techniques
  • Cancer Immunotherapy and Biomarkers

Keywords (DOAJ)

  • breast neoplasms
  • mammography

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: